New Solution for Healing Skin

A patented precursor to human elastin, developed originally in a war-wound project, aids tissue regeneration and scar-free healing of skin.

Elastotropin, the elastin precursor, enters into the outer skin layers, cross-links with collagen and other proteins, replenishing sufficient elastin to also slow or prevent wrinkles and facial sagging. It is based on patents and technology originally developed in connection with the Defense Advanced Research Project Agency (DARPA) of the U.S. Department of Defense (Washington, C, USA). Elastotropin is the main ingredient in a new product called DermaLastyl, manufactured by Derma Plus (New York, NY, USA).

"We learned on the DARPA project how to make synthesized human elastin to heal war wounds with reduced scarring. Since elastin is absent in fresh wounds, the cells are not held together by tissues that provide support and flexibility. This lack of elastin directly leads to the formation of excess scar tissue,” explained Dr. Burt Ensley, of the Universities of Arizona and Northern Arizona. Dr. Ensley was on the Biologic Sciences Directorate Advisory Council of the U.S. National Science Foundation (NSF).

"Botox injections, painful and dangerous, now have a safe alternative. DermaLastyl will also reduce the need for cosmetic surgery since it tightens the skin and extends the life of previous surgery,” concluded Dr. Ensley.




Related Links:
DermaLastyl